Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

Prof

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47296

Office COP300

Email jamie-miller@ou.edu


Publications & Presentations

    46. Moore E, Mayes R, Harkin M, Miller J L, Johnson P N. Extended Duration Ketamine Infusions in Critically Ill Children: A Case Report and Review of the Literature. Journal of pediatric intensive care. 2021; 10 : 221-227

    47. Stephens K, Barker P, Bergeron E, Miller J L, Hagemann T M, Lewis T V, Neely S, Johnson P N. Comparison of Clinical Outcomes and Medication Use of Obese Versus Nonobese Children Admitted to the Pediatric Intensive Care Unit. Hospital pharmacy. 2021; 56 : 287-295

    48. Harkin M, Miller J L, Lim S Y, Neely S, Walsh C, Johnson P N. "Reply: Conversion From Continuous Infusion Fentanyl to Hydromorphone in the Pediatric Intensive Care Unit". The Annals of pharmacotherapy. 2021

    49. Miller J L, Stephens K, Johnson P N, Medina M. Teaching residents how to deliver active learning during didactic lectures. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2021; 78 : 944-948

    50. Miller J L. Neonatal Disease. Hunan Science and Technology Press. 2021 : 585-598




Grants

1 2 >>
    1. Selenium Pharmacokinetics and Pharmacodynamics of Infants with Intestinal Failure a Prospective Cohort Study. Misc Non-Federal. Start Date: 2025. End Date: 2026.

    2. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

    3. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

    4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    5. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

1 2 >>



Awards and Honors

<< 1 2 3 4 5 >>
                                                                                            6. American Society of Health-System Pharmacists. Fellow of American Society of Health-System Pharmacists. Date: 2024.  

                                                                                            7. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.  

                                                                                            8. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.  

                                                                                            9. University of Oklahoma Health Sciences Center. President's Associates Presidential Professorship. Date: 2023.  

                                                                                            10. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.  

<< 1 2 3 4 5 >>



Education

                                                                                            1.  Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.  

                                                                                            2.  Degree: BS. Trevecca Nazarene University. Date: 2002.  




Administrative Assignments

                                                

    1. Role: Department Vice-Chair. Scope: Department. Date: 2021.